RGC
NASDAQ · Pharmaceuticals
Regencell Bioscience Holding
$24.15
-0.28 (-1.13%)
Performance
1D
—
1W
—
1M
—
3M
+14.13%
6M
+47.35%
1Y
+2,265.10%
YTD
+17.58%
Open$24.82
Previous Close$24.43
Day High$25.97
Day Low$24.03
52W High$83.60
52W Low—
Volume—
Avg Volume158.4K
Market Cap13.36B
P/E Ratio—
EPS$-0.01
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$27.08
Below
SMA 200
$18.57
Above
RSI (14)
63.8
Neutral
Trend
Golden Cross
Bullish
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 3.66B | 3.76B | 3.59B |
| Net Income | 706.46M | 788.49M | 815.65M |
| Profit Margin | 19.3% | 21.0% | 22.7% |
| EBITDA | 1.06B | 1.04B | 1.04B |
| Free Cash Flow | 809.03M | 638.27M | 648.55M |
| Rev Growth | +1.6% | +15.1% | +20.8% |
| Debt/Equity | 0.23 | 0.28 | 0.31 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |